Ohuchi Masanobu, Asaoka Naoko, Sakai Tatsuya, Ohuchi Reiko
Department of Microbiology, Kawasaki Medical School, 577 Matsushima, Kurashiki 710-0192, Japan.
Microbes Infect. 2006 Apr;8(5):1287-93. doi: 10.1016/j.micinf.2005.12.008. Epub 2006 Feb 8.
We propose a concept that neuraminidase (NA) promotes virus entry into target cells during the initial stage of viral infection, in addition to the generally accepted concept that influenza virus NA promotes the release of progeny virus from a host cell at the final stage of viral replication. When NA activity was inhibited with specific inhibitors such as zanamivir and oseltamivir carboxylate, infection efficiency of the virus to MDCK and A549 cells was reduced to approximately 1/4 and 1/8, respectively. NA inhibitors did not significantly affect virus binding and envelope fusion activities, when assessed using an erythrocyte and virus system. Since the initial stage of viral infection involves binding of the virus to the target cell, virus entry into an endosome and envelope fusion with the endosomal membrane, our results indicated that NA inhibitors interfered with the virus entry step. Thus, NA is thought to promote virus entry, and thereby enhances infection efficiency.
我们提出了一个概念,即除了普遍接受的流感病毒神经氨酸酶(NA)在病毒复制的最后阶段促进子代病毒从宿主细胞释放这一概念外,NA在病毒感染的初始阶段也促进病毒进入靶细胞。当用扎那米韦和奥司他韦羧酸盐等特异性抑制剂抑制NA活性时,病毒对MDCK和A549细胞的感染效率分别降至约1/4和1/8。当使用红细胞和病毒系统进行评估时,NA抑制剂对病毒结合和包膜融合活性没有显著影响。由于病毒感染的初始阶段涉及病毒与靶细胞的结合、病毒进入内体以及包膜与内体膜的融合,我们的结果表明NA抑制剂干扰了病毒进入步骤。因此,NA被认为可促进病毒进入,从而提高感染效率。